{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T12:53:53Z","timestamp":1783947233098,"version":"3.55.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-025-04051-8","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T06:06:56Z","timestamp":1765174016000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The prevalence of Mycobacterium tuberculosis and rifampicin-resistance strains using GeneXpert-MTB\/RIF assay in Ethiopia: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Mengistu","family":"Abayneh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Zeynudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yared","family":"Alemu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teshome","family":"Degefa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulhakim","family":"Abamecha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mulualem","family":"Tadesse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abraham Tamirat","family":"Gizaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"issue":"Suppl 6","key":"4051_CR1","doi-asserted-by":"publisher","first-page":"S629","DOI":"10.1093\/infdis\/jix362","volume":"216","author":"G Churchyard","year":"2017","unstructured":"Churchyard G, Kim P, Shah NS, Rustomjee R, Gandhi N, et al. What we know about tuberculosis transmission: an overview. J Infect Dis. 2017;216(Suppl 6):S629. https:\/\/doi.org\/10.1093\/infdis\/jix362.","journal-title":"J Infect Dis"},{"key":"4051_CR2","doi-asserted-by":"publisher","unstructured":"Richard Long, Maziar Divangahi & Kevin Schwartzman (2022) Chapter 2: Transmission and pathogenesis of tuberculosis, Canadian Journal of Respiratory, Critical Care, and Sleep Medicine, 6:sup1, 22-32, https:\/\/doi.org\/10.1080\/24745332.2022.2035540.","DOI":"10.1080\/24745332.2022.2035540"},{"key":"4051_CR3","doi-asserted-by":"crossref","unstructured":"National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.). Division of Tuberculosis Elimination. Transmission and pathogenesis of tuberculosis (2019)., Molla KA, Reta MA, Ayene YY. Prevalence of multidrug-resistant tuberculosis in East Africa: A systematic review and meta-analysis. PLoS ONE. 2022;17(6):e0270272.","DOI":"10.1371\/journal.pone.0270272"},{"issue":"6","key":"4051_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0270272","volume":"17","author":"KA Molla","year":"2022","unstructured":"Molla KA, Reta MA, Ayene YY. Prevalence of multidrug-resistant tuberculosis in East Africa: A systematic review and meta-analysis. PLoS ONE. 2022;17(6): e0270272.","journal-title":"PLoS ONE."},{"issue":"9","key":"4051_CR5","doi-asserted-by":"publisher","first-page":"e1132","DOI":"10.1016\/S2214-109X(20)30288-6","volume":"8","author":"AB Hogan","year":"2020","unstructured":"Hogan AB, Jewell BL, Sherrard-Smith E, et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: A modelling study. Lancet Global Health. 2020;8(9):e1132. https:\/\/doi.org\/10.1016\/S2214-109X(20)30288-6.","journal-title":"Lancet Global Health"},{"issue":"1","key":"4051_CR6","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pulmoe.2020.05.013","volume":"27","author":"D Buonsenso","year":"2021","unstructured":"Buonsenso D, Iodice F, Biala JS, Goletti D. COVID-19 effects on tuberculosis care in Sierra Leone. Pulmonology. 2021;27(1):67\u20139. https:\/\/doi.org\/10.1016\/j.pulmoe.2020.05.013.","journal-title":"Pulmonology"},{"key":"4051_CR7","doi-asserted-by":"publisher","unstructured":"Cilloni L, Fu H, Vesga JF, Dowdy D, Pretorius C, Ahmedov S, et al. The potential impact of the COVID-19 pandemic on the tuberculosis epidemic a modelling analysis. EClinical Med. 2020;28. https:\/\/doi.org\/10.1016\/j.eclinm.2020.100603.","DOI":"10.1016\/j.eclinm.2020.100603"},{"key":"4051_CR8","unstructured":"Global tuberculosis report 2024. Geneva, World Health Organization. : 2024. License: CC BY-NC-SA 3.0 IGO."},{"key":"4051_CR9","unstructured":"Tuberculosis in the WHO African Region: 2023 progress update. Brazzaville: WHO African Region, 2023. Licence: CC BY-NC-SA 3.0 IGO."},{"key":"4051_CR10","doi-asserted-by":"publisher","first-page":"100278","DOI":"10.1016\/j.jctube.2021.100278","volume":"25","author":"NP Mnyambwa","year":"2021","unstructured":"Mnyambwa NP, Philbert D, Kimaro G, Wandiga S, Kirenga B, et al. Gaps related to screening and diagnosis of tuberculosis in care cascade in selected health facilities in East Africa countries: A retrospective study. J Clin Tuberculosis Other Mycobact Dis. 2021;25:100278. https:\/\/doi.org\/10.1016\/j.jctube.2021.100278.","journal-title":"J Clin Tuberculosis Other Mycobact Dis"},{"key":"4051_CR11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1186\/s12879-023-08502-7","volume":"23","author":"MD Fenta","year":"2023","unstructured":"Fenta MD, Ogundijo OA, Warsame AAA, et al. Facilitators and barriers to tuberculosis active case findings in low- and middle-income countries: a systematic review of qualitative research. BMC Infect Dis. 2023;23:515. https:\/\/doi.org\/10.1186\/s12879-023-08502-7.","journal-title":"BMC Infect Dis"},{"issue":"7","key":"4051_CR12","doi-asserted-by":"publisher","first-page":"136","DOI":"10.3390\/tropicalmed7070136","volume":"7","author":"HD Shah","year":"2022","unstructured":"Shah HD, Nazli Khatib M, Syed ZQ, Gaidhane AM, Yasobant S, et al. Gaps and interventions across the diagnostic care cascade of TB patients at the level of Patient, community and health system: A qualitative review of the literature. Trop Med Infect Disease. 2022;7(7):136. https:\/\/doi.org\/10.3390\/tropicalmed7070136.","journal-title":"Trop Med Infect Disease"},{"key":"4051_CR13","doi-asserted-by":"publisher","first-page":"e053290","DOI":"10.1136\/bmjopen-2021-053290","volume":"12","author":"B Arega","year":"2022","unstructured":"Arega B, Negesso A, Taye B, et al. Impact of COVID-19 pandemic on TB prevention and care in addis Ababa, ethiopia: a retrospective database study. BMJ Open. 2022;12:e053290. https:\/\/doi.org\/10.1136\/bmjopen-2021-053290.","journal-title":"BMJ Open"},{"key":"4051_CR14","unstructured":"Khatri U, Davis N Quality of Tuberculosis Services Assessment in Ethiopia: Report. Chapel Hill, NC, USA: MEASURE Evaluation, University of North Carolina. 2020"},{"key":"4051_CR15","doi-asserted-by":"publisher","unstructured":"Getahun DA, Layland LE, Hoerauf A, Wondale B. Impact of the use of GeneXpert on TB diagnosis and anti-TB treatment outcome at health facilities in Addis Ababa, Ethiopia in the post-millennium development years. PLoS ONE. 2023;18(8):e0289917. https:\/\/doi.org\/10.1371\/journal.pone.0289917.","DOI":"10.1371\/journal.pone.0289917"},{"key":"4051_CR16","doi-asserted-by":"publisher","unstructured":"Steingart KR, Schiller I, Horne DJ, Pai M, et al. Xpert\u00ae MTB\/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2014;2014(1). https:\/\/doi.org\/10.1002\/14651858.CD009593.pub3.","DOI":"10.1002\/14651858.CD009593.pub3"},{"key":"4051_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12913-020-4997-x","volume":"20","author":"T Nalugwa","year":"2020","unstructured":"Nalugwa T, Shete PB, Nantale M, et al. Challenges with scale-up of GeneXpert MTB\/RIF\u00ae in uganda: a health systems perspective. BMC Health Serv Res. 2020;20:162. https:\/\/doi.org\/10.1186\/s12913-020-4997-x.","journal-title":"BMC Health Serv Res"},{"key":"4051_CR18","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. http:\/\/www.prisma-statement.org\/.","journal-title":"BMJ"},{"issue":"3","key":"4051_CR19","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/XEB.0000000000000055","volume":"13","author":"E Aromataris","year":"2015","unstructured":"Aromataris E, Fernandez R, Godfrey CM, Holly C, Khalil H, Tungpunkom P. Summarizing systematic reviews: methodological development, conduct and reporting of an umbrella review approach. Int J Evid Based Healthc. 2015;13(3):132\u201340.","journal-title":"Int J Evid Based Healthc"},{"key":"4051_CR20","unstructured":"Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA, editors. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane. 2022. Available from; www.training.cochrane.org\/handbook."},{"issue":"2","key":"4051_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","volume":"11","author":"TB Huedo-Medina","year":"2006","unstructured":"Huedo-Medina TB, S\u00e1nchez-Meca J, Mar\u00edn-Mart\u00ednez F, Botella J. Assessing heterogeneity in meta-analysis: Q statistic or I \u00b2 index? Psychol Methods 2006; 11(2), 193\u2013206. https:\/\/doi.org\/10.1037\/1082-989X.11.2.193.","journal-title":"Psychol Methods"},{"key":"4051_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40794-020-00115-1","volume":"6","author":"GK Abay","year":"2020","unstructured":"Abay GK, Abraha BH. Trends of Mycobacterium tuberculosis and rifampicin resistance in adigrat general Hospital, Eastern zone of Tigrai, North Ethiopia. Trop Dis Travel Med Vaccines. 2020;6:14. https:\/\/doi.org\/10.1186\/s40794-020-00115-1.","journal-title":"Trop Dis Travel Med Vaccines"},{"issue":"11","key":"4051_CR23","doi-asserted-by":"publisher","first-page":"e0277536","DOI":"10.1371\/journal.pone.0277536","volume":"17","author":"M Abayneh","year":"2022","unstructured":"Abayneh M, Teressa M. Detection of Mycobacterium tuberculosis using gene Xpert-MTB\/RIF assay among tuberculosis suspected patients at Mizan-Tepi university teaching hospital, Southwest ethiopia: an institution based cross-sectional study. PLoS ONE. 2022;17(11):e0277536. https:\/\/doi.org\/10.1371\/journal.pone.0277536.","journal-title":"PLoS ONE"},{"issue":"1","key":"4051_CR24","doi-asserted-by":"publisher","first-page":"e0262929","DOI":"10.1371\/journal.pone.0262929","volume":"17","author":"W Admassu","year":"2022","unstructured":"Admassu W, Ayelign B, Abebe G, Tadesse M. Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert\u00ae MTB\/RIF assay among presumptive tuberculosis cases at Jimma university medical Center, Southwest Ethiopia. PLoS ONE. 2022;17(1):e0262929. https:\/\/doi.org\/10.1371\/journal.pone.0262929.","journal-title":"PLoS ONE"},{"issue":"12","key":"4051_CR25","doi-asserted-by":"publisher","first-page":"e0277145","DOI":"10.1371\/journal.pone.0277145","volume":"17","author":"GT Akalu","year":"2022","unstructured":"Akalu GT, Tessema B, Petros B. High proportion of RR-TB and mutations conferring RR outside of the RRDR of the RpoB gene detected in GeneXpert MTB\/RIF assay positive pulmonary tuberculosis cases, in addis Ababa, Ethiopia. PLoS ONE. 2022;17(12):e0277145. https:\/\/doi.org\/10.1371\/journal.pone.0277145.","journal-title":"PLoS ONE"},{"key":"4051_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.ijregi.2023.03.007","volume":"7","author":"E Alehegn","year":"2023","unstructured":"Alehegn E, Gebreyohanns A, Berhane B, Wright J, Fantahun M, Hailu M, et al. Burden of Mycobacterium tuberculosis and associated factors among presumptive extra pulmonary tuberculosis patients from selected health Facilities, addis Ababa, Ethiopia. IJID Reg. 2023;7:199\u2013205. https:\/\/doi.org\/10.1016\/j.ijregi.2023.03.007.","journal-title":"IJID Reg"},{"key":"4051_CR27","doi-asserted-by":"publisher","unstructured":"Andarge DB, Anticho TL, Jara GM, Ali MM. (2021). Prevalence of Mycobacterium tuberculosis infection and rifampicin resistance among presumptive tuberculosis cases visiting tuberculosis clinic of Adare General Hospital, Southern Ethiopia. SAGE Open Medicine. 2021; https:\/\/doi.org\/10.1177\/20503121211045541.","DOI":"10.1177\/20503121211045541"},{"key":"4051_CR28","doi-asserted-by":"publisher","unstructured":"Arega B, Menbere F, Getachew Y. Prevalence of rifampicin resistant Mycobacterium tuberculosis among presumptive tuberculosis patients in selected governmental hospitals in Addis Ababa, Ethiopia. BMC Infect Dis. 2019;19, 307 (2019). https:\/\/doi.org\/10.1186\/s12879-019-3943-1.","DOI":"10.1186\/s12879-019-3943-1"},{"key":"4051_CR29","doi-asserted-by":"publisher","first-page":"3451","DOI":"10.2147\/IDR.S263023","volume":"13","author":"S Araya","year":"2020","unstructured":"Araya S, Negesso AE, Tamir Z. Rifampicin-Resistant Mycobacterium tuberculosis among patients with presumptive tuberculosis in addis Ababa, Ethiopia. Infect Drug Resist. 2020;13:3451\u20139. https:\/\/doi.org\/10.2147\/IDR.S263023.","journal-title":"Infect Drug Resist"},{"key":"4051_CR30","doi-asserted-by":"publisher","first-page":"3863","DOI":"10.2147\/IDR.S277222","volume":"13","author":"ML Ayalew","year":"2020","unstructured":"Ayalew ML, Yigzaw WB, Tigabu A, Tarekegn BG, Prevalence. Associated risk factors and rifampicin resistance pattern of pulmonary tuberculosis among children at Debre Markos referral Hospital, Northwest, Ethiopia. Infect Drug Resist. 2020;13:3863\u201372. https:\/\/doi.org\/10.2147\/IDR.S277222.","journal-title":"Infect Drug Resist"},{"key":"4051_CR31","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1155\/2017\/3826980","volume":"2017","author":"MG Beza","year":"2017","unstructured":"Beza MG, Hunegnaw E, Tiruneh M. Prevalence and associated factors of tuberculosis in prisons settings of East Gojjam Zone, Northwest Ethiopia. Int J Bacteriol. 2017;2017:7. https:\/\/doi.org\/10.1155\/2017\/3826980.","journal-title":"Int J Bacteriol"},{"key":"4051_CR32","doi-asserted-by":"publisher","first-page":"6757","DOI":"10.2147\/IDR.S433789","volume":"16","author":"TA Dejene","year":"2023","unstructured":"Dejene TA, Hailu GG, Kahsay AG, Wasihun AG. Pulmonary tuberculosis and rifampicin resistant Mycobacterium tuberculosis in children and adolescents using gene Xpert MTB\/RIF assay in Tigray, Northern Ethiopia. Infect Drug Resist. 2023;16:6757\u201365. https:\/\/doi.org\/10.2147\/IDR.S433789.","journal-title":"Infect Drug Resist"},{"key":"4051_CR33","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.2147\/IDR.S300585","volume":"14","author":"TA Demissie","year":"2021","unstructured":"Demissie TA, Belayneh D. Magnitude of Mycobacterium tuberculosis infection and its resistance to rifampicin using Xpert-MTB\/RIF assay among presumptive tuberculosis patients at Motta general Hospital, Northwest Ethiopia. Infect Drug Resist. 2021;14:1335\u201341. https:\/\/doi.org\/10.2147\/IDR.S300585.","journal-title":"Infect Drug Resist"},{"issue":"2","key":"4051_CR34","first-page":"60","volume":"30","author":"A Derbie","year":"2016","unstructured":"Derbie A, Worku S, Mekonnen D, Mezgebu Y, Teshager A, et al. Xpert MTB\/RIF assay for the diagnosis of Mycobacterium tuberculosis and its rifampicin resistance at Felege Hiwot and Debre Tabor Hospitals, Northwest ethiopia: A preliminary implementation research. Ethiop J Health Dev. 2016;30(2):60\u20136.","journal-title":"Ethiop J Health Dev"},{"key":"4051_CR35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.ijregi.2022.09.001","volume":"5","author":"G Diriba","year":"2022","unstructured":"Diriba G, Alemu A, Tola HH, Eshetu K, Yenew B, et al. Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert\u00ae MTB\/RIF assay among presumptive tuberculosis patients in addis Ababa, Ethiopia from 2014 to 2021. IJID Reg. 2022;5:97\u2013103. https:\/\/doi.org\/10.1016\/j.ijregi.2022.09.001.","journal-title":"IJID Reg"},{"key":"4051_CR36","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.2147\/IDR.S327607","volume":"14","author":"K Diriba","year":"2021","unstructured":"Diriba K, Awulachew E, Churiso G. The magnitude of MTB and rifampicin resistance MTB using Xpert-MTB\/RIF assay among tuberculosis suspected patients in Gedeo Zone, Southern Ethiopia. Infect Drug Resist. 2021;14:3961\u20139. https:\/\/doi.org\/10.2147\/IDR.S327607.","journal-title":"Infect Drug Resist"},{"key":"4051_CR37","doi-asserted-by":"publisher","unstructured":"Diriba K, Churiso G. The prevalence of Mycobacterium tuberculosis using gene Xpert among tuberculosis suspected patients in Gedeo Zone, Southern Ethiopia. Eur J Med Res. 2022;27. https:\/\/doi.org\/10.1186\/s40001-022-00650-x.","DOI":"10.1186\/s40001-022-00650-x"},{"key":"4051_CR38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jctube.2018.06.002","volume":"12","author":"E Ejeta","year":"2018","unstructured":"Ejeta E, Beyene G, Bonsa Z, Abebe G. Xpert MTB\/RIF assay for the diagnosis of Mycobacterium tuberculosis and rifampicin resistance in high human immunodeficiency virus setting in Gambella regional state, Southwest Ethiopia. J Clin Tuberculosis Other Mycobact Dis. 2018;12:14\u201320. https:\/\/doi.org\/10.1016\/j.jctube.2018.06.002.","journal-title":"J Clin Tuberculosis Other Mycobact Dis"},{"issue":"3","key":"4051_CR39","doi-asserted-by":"publisher","first-page":"e0150646","DOI":"10.1371\/journal.pone.0150646","volume":"11","author":"A Fanosie","year":"2016","unstructured":"Fanosie A, Gelaw B, Tessema B, Tesfay W, Admasu A, Yitayew G. Mycobacterium tuberculosis complex and HIV Co-Infection among extrapulmonary tuberculosis suspected cases at the university of Gondar Hospital, Northwestern Ethiopia. PLoS ONE. 2016;11(3):e0150646. https:\/\/doi.org\/10.1371\/journal.pone.0150646 .","journal-title":"PLoS ONE"},{"issue":"01","key":"4051_CR40","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3855\/jidc.10462","volume":"13","author":"GB Gebrehiwet","year":"2019","unstructured":"Gebrehiwet GB, Kahsay AG, Welekidan LN, Hagos AK, et al. Rifampicin resistant tuberculosis in presumptive pulmonary tuberculosis cases in Dubti Hospital, Afar, Ethiopia. J Infect Dev Ctries. 2019;13(01):21\u20137. https:\/\/doi.org\/10.3855\/jidc.10462.","journal-title":"J Infect Dev Ctries"},{"key":"4051_CR41","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.2147\/IDR.S248059","volume":"13","author":"D Gebretsadik","year":"2020","unstructured":"Gebretsadik D, Ahmed N, Kebede E, Mohammed M, Belete MA. Prevalence of tuberculosis by automated GeneXpert rifampicin assay and associated risk factors among presumptive pulmonary tuberculosis patients at Ataye district Hospital, Northeast Ethiopia. Infect Drug Resist. 2020;13:1507\u201316. https:\/\/doi.org\/10.2147\/IDR.S248059.","journal-title":"Infect Drug Resist"},{"key":"4051_CR42","first-page":"883","volume":"15","author":"A Haile","year":"2021","unstructured":"Haile A, Haile K, Shemsu S. Trend and associated factors of Mycobacterium tuberculosis and rifampicin resistance in South-west ethiopia: institutional based retrospective study. Health Sci J. 2021;15:9: 883.","journal-title":"Health Sci J"},{"key":"4051_CR43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2147\/IDR.S135935","volume":"10","author":"KN Jaleta","year":"2017","unstructured":"Jaleta KN, Gizachew M, Gelaw B, Tesfa H, Getaneh A, Biadgo B. Rifampicin-resistant Mycobacterium tuberculosis among tuberculosis-presumptive cases at university of Gondar Hospital, Northwest Ethiopia. Infect Drug Resist. 2017;10:185\u201392. https:\/\/doi.org\/10.2147\/IDR.S135935.","journal-title":"Infect Drug Resist"},{"issue":"8","key":"4051_CR44","doi-asserted-by":"publisher","first-page":"e0272459","DOI":"10.1371\/journal.pone.0272459","volume":"17","author":"M Kassa","year":"2022","unstructured":"Kassa M, Desta K, Ambachew R, Gebreyohannes Z, et al. Magnitude of Mycobacterium tuberculosis, drug resistance and associated factors among presumptive tuberculosis patients at St. Paul\u2019s hospital millennium medical College, addis Ababa, Ethiopia. PLoS ONE. 2022;17(8):e0272459. https:\/\/doi.org\/10.1371\/journal.pone.0272459.","journal-title":"PLoS ONE"},{"key":"4051_CR45","doi-asserted-by":"publisher","unstructured":"Kelecha WT, Teklegiorgis S, Gemechu M. Rifampicin-resistance pattern of Mycobacterium tuberculosis and associated risk factors among presumptive pulmonary and extra pulmonary tuberculosis patients at Madda Walabu university Goba referral Hospital, Southeast Ethiopia. 2021. https:\/\/doi.org\/10.21203\/rs.3.rs-652594\/v1.","DOI":"10.21203\/rs.3.rs-652594\/v1"},{"issue":"1","key":"4051_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-43206-7","volume":"13","author":"H Kumbi","year":"2023","unstructured":"Kumbi H, Reda DY, Solomon M, Teklehaimanot A, Ormago MD, Ali MM. Magnitude of tuberculosis lymphadenitis, risk factors, and rifampicin resistance at Adama city, ethiopia: A cross-sectional study. Sci Rep. 2023;13(1):1\u20138. https:\/\/doi.org\/10.1038\/s41598-023-43206-7.","journal-title":"Sci Rep"},{"key":"4051_CR47","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1186\/s12879-023-08469-5","volume":"23","author":"A Meaza","year":"2023","unstructured":"Meaza A, Yenew B, Amare M, et al. Prevalence of tuberculosis and associated factors among presumptive TB refugees residing in refugee camps in Ethiopia. BMC Infect Dis. 2023;23:498. https:\/\/doi.org\/10.1186\/s12879-023-08469-5.","journal-title":"BMC Infect Dis"},{"key":"4051_CR48","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8207098","author":"Y Metaferia","year":"2018","unstructured":"Metaferia Y, Seid A, Fenta GM, Gebretsadik D. Assessment of extrapulmonary tuberculosis using gene Xpert MTB\/RIF assay and fluorescent microscopy and its risk factors at Dessie referral Hospital, Northeast Ethiopia. Biomed Res Int. 2018. https:\/\/doi.org\/10.1155\/2018\/8207098.","journal-title":"Biomed Res Int"},{"key":"4051_CR49","doi-asserted-by":"publisher","first-page":"805726","DOI":"10.3389\/fpubh.2021.805726","volume":"9","author":"H Mohammed","year":"2022","unstructured":"Mohammed H, Oljira L, Roba KT, Ngadaya E, Manyazewal T, et al. Tuberculosis prevalence and predictors among health Care-Seeking people screened for cough of any duration in ethiopia: A multicenter Cross-Sectional study. Front Public Health. 2022;9:805726. https:\/\/doi.org\/10.3389\/fpubh.2021.805726.","journal-title":"Front Public Health"},{"key":"4051_CR50","doi-asserted-by":"publisher","unstructured":"Mulu W, Abera B, Yimer M, Hailu T, et al. Rifampicin-resistance pattern of Mycobacterium tuberculosis and associated factors among presumptive tuberculosis patients referred to Debre Markos referral Hospital, ethiopia: A cross-sectional study. BMC Res Notes. 2017;10. https:\/\/doi.org\/10.1186\/s13104-016-2328-4.","DOI":"10.1186\/s13104-016-2328-4"},{"key":"4051_CR51","doi-asserted-by":"publisher","unstructured":"Selfegna S, Alelign A. Detection of Mycobacterium tuberculosis and rifampicin resistance using GeneXpert MTB\/RIF assay at Enat Hospital, central Ethiopia. Tuberculosis Res Treat. 2022;7. https:\/\/doi.org\/10.1155\/2022\/1250404.","DOI":"10.1155\/2022\/1250404"},{"issue":"2","key":"4051_CR52","doi-asserted-by":"publisher","first-page":"e0263172","DOI":"10.1371\/journal.pone.0263172","volume":"17","author":"A Simieneh","year":"2022","unstructured":"Simieneh A, Tadesse M, Kebede W, Gashaw M, Abebe G. Combination of Xpert\u00ae MTB\/RIF and determine TM TB-LAM ag improves the diagnosis of extrapulmonary tuberculosis at Jimma university medical Center, Oromia, Ethiopia. PLoS ONE. 2022;17(2):e0263172. https:\/\/doi.org\/10.1371\/journal.pone.0263172.","journal-title":"PLoS ONE"},{"key":"4051_CR53","doi-asserted-by":"publisher","unstructured":"Sinshaw W, Kebede A, Bitew A, Tadesse M, Mehamed Z, et al. Effect of sputum quality and role of Xpert\u00ae MTB\/ RIF assay for detection of smear-negative pulmonary tuberculosis in same-day diagnosis strategy in Addis Ababa, Ethiopia. Afr J Lab Med. 2022;11(1). https:\/\/doi.org\/10.4102\/ajlm.v11i1.1671.","DOI":"10.4102\/ajlm.v11i1.1671"},{"issue":"3","key":"4051_CR54","doi-asserted-by":"publisher","first-page":"449","DOI":"10.4103\/ejcdt.ejcdt_49_19","volume":"69","author":"E Tedla","year":"2020","unstructured":"Tedla E, Ayalew G, Mekonnen F. Mycobacterium tuberculosis burden, multidrug resistance pattern, and associated risk factors among presumptive extrapulmonary tuberculosis cases at Dessie referral Hospital, Northeast Ethiopia. Egypt J Chest Dis Tuberculosis. 2020;69(3):449\u201354. https:\/\/doi.org\/10.4103\/ejcdt.ejcdt_49_19.","journal-title":"Egypt J Chest Dis Tuberculosis"},{"key":"4051_CR55","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1186\/s12879-021-06807-z","volume":"21","author":"E Temesgen","year":"2021","unstructured":"Temesgen E, Belete Y, Haile K, et al. Prevalence of active tuberculosis and associated factors among people with chronic psychotic disorders at St. Amanuel mental specialized hospital and Gergesenon mental rehabilitation center, addis Ababa, Ethiopia. BMC Infect Dis. 2021;21:1100. https:\/\/doi.org\/10.1186\/s12879-021-06807-z.","journal-title":"BMC Infect Dis"},{"key":"4051_CR56","doi-asserted-by":"publisher","unstructured":"Toru M, Baye A, Gebeyehu Z, Abebaw A, Reta A. Prevalence, associated factors and rifampicin resistance pattern of pulmonary tuberculosis among HIV-positive patients attending antiretroviral treatment clinic at East Gojjam Zone, ethiopia: an institution-based cross-sectional study. J Clin Tuberculosis Other Mycobact Dis. 2022;29. https:\/\/doi.org\/10.1016\/j.jctube.2022.100336.","DOI":"10.1016\/j.jctube.2022.100336"},{"issue":"11","key":"4051_CR57","doi-asserted-by":"publisher","first-page":"e0240361","DOI":"10.1371\/journal.pone.0240361","volume":"15","author":"AG Wasihun","year":"2020","unstructured":"Wasihun AG, Dejene TA, Hailu GG. Frequency of MTB and rifampicin resistance MTB using Xpert-MTB\/RIF assay among adult presumptive tuberculosis patients in Tigray, Northern ethiopia: A cross sectional study. PLoS ONE. 2020;15(11):e0240361. https:\/\/doi.org\/10.1371\/journal.pone.0240361.","journal-title":"PLoS ONE"},{"key":"4051_CR58","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1007\/s40121-020-00368-5","volume":"10","author":"AG Wasihun","year":"2021","unstructured":"Wasihun AG, Hailu GG, Dejene TA. Prevalence of Mycobacterium tuberculosis (Rifampicin-Resistant MTB) and associated risk actors among pulmonary presumptive TB patients in Eastern Amhara, ethiopia: 2015\u20132019. Infect Dis Ther. 2021;10:1299\u2013308. https:\/\/doi.org\/10.1007\/s40121-020-00368-5.","journal-title":"Infect Dis Ther"},{"key":"4051_CR59","doi-asserted-by":"publisher","unstructured":"Worku M, Agonafir M, Yassin MA, Yassin MA, Datiko DG, Theobald S, Cuevas LE. Use of Xpert MTB\/RIF for the identification of TB and drug resistance among smear-negative and re-treatment cases in rural areas of Ethiopia. Open Microbiol J. 2019;13(1). https:\/\/doi.org\/10.2174\/1874285801913010188.","DOI":"10.2174\/1874285801913010188"},{"key":"4051_CR60","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.2147\/IDR.S274589","volume":"13","author":"O Zewdie","year":"2020","unstructured":"Zewdie O, Dabsu R, Kifle E, Befikadu D. Rifampicin-Resistant Multidrug-Resistant tuberculosis cases in selected hospitals in Western Oromia, ethiopia: Cross-Sectional retrospective study. Infect Drug Resist. 2020;13:3699\u2013705. https:\/\/doi.org\/10.2147\/IDR.S274589.","journal-title":"Infect Drug Resist"},{"key":"4051_CR61","doi-asserted-by":"publisher","first-page":"100158","DOI":"10.1016\/j.jctube.2020.100158","volume":"19","author":"H Mohammed","year":"2020","unstructured":"Mohammed H, Oljira L, Roba KT, Ngadaya E, et al. Burden of tuberculosis and challenges related to screening and diagnosis in Ethiopia. J Clin Tuberculosis Other Mycobact Dis. 2020;19:100158. https:\/\/doi.org\/10.1016\/j.jctube.2020.100158.","journal-title":"J Clin Tuberculosis Other Mycobact Dis"},{"key":"4051_CR62","doi-asserted-by":"publisher","first-page":"1555901","DOI":"10.3389\/fpubh.2025.1555901","volume":"13","author":"W Abebe","year":"2025","unstructured":"Abebe W, Gedifie S, Emagneneh T. Prevalence of tuberculosis in ethiopia: an umbrella review of systematic review and meta-analysis. Front Public Health. 2025;13:1555901. https:\/\/doi.org\/10.3389\/fpubh.2025.1555901.","journal-title":"Front Public Health"},{"key":"4051_CR63","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12890-024-02865-6","volume":"24","author":"MM Badawi","year":"2024","unstructured":"Badawi MM, SalahEldin MA, Idris AB, et al. Tuberculosis in sudan: systematic review and meta-analysis. BMC Pulm Med. 2024;24:51. https:\/\/doi.org\/10.1186\/s12890-024-02865-6.","journal-title":"BMC Pulm Med"},{"issue":"9","key":"4051_CR64","doi-asserted-by":"publisher","first-page":"e0331035","DOI":"10.1371\/journal.pone.0331035","volume":"20","author":"L Yismaw","year":"2025","unstructured":"Yismaw L, Zewotir T, Muluneh EK, Getnet F, Getinet K, Getahun HA, et al. Burden of tuberculosis in Eastern Africa region from 1990\u20132021: A systematic analysis for the global burden of disease 2021 study. PLoS ONE. 2025;20(9):e0331035. https:\/\/doi.org\/10.1371\/journal.pone.0331035.","journal-title":"PLoS ONE"},{"issue":"10","key":"4051_CR65","doi-asserted-by":"publisher","first-page":"e0259056","DOI":"10.1371\/journal.pone.0259056","volume":"16","author":"AW Kaso","year":"2021","unstructured":"Kaso AW, Hailu A. Costs and cost-effectiveness of gene Xpert compared to smear microscopy for the diagnosis of pulmonary tuberculosis using real-world data from Arsi zone, Ethiopia. PLoS ONE. 2021;16(10):e0259056. https:\/\/doi.org\/10.1371\/journal.pone.0259056.","journal-title":"PLoS ONE"},{"key":"4051_CR66","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ijid.2016.07.002","volume":"49","author":"D Habte","year":"2016","unstructured":"Habte D, Melese M, Hiruy N, Gashu Z, Jerene D, et al. The additional yield of GeneXpert MTB\/RIF test in the diagnosis of pulmonary tuberculosis among household contacts of smear positive TB cases. Int J Infect Dis. 2016;49:179\u201384. https:\/\/doi.org\/10.1016\/j.ijid.2016.07.002.","journal-title":"Int J Infect Dis"},{"key":"4051_CR67","doi-asserted-by":"publisher","first-page":"221","DOI":"10.18203\/issn.2454-2156.IntJSciRep20221842","volume":"8","author":"M John","year":"2022","unstructured":"John M, Oleka. Evans. First-line drug resistance of Mycobacterium tuberculosis strains in Sub-Saharan Africa. Int J Sci Rep. 2022;8:221. https:\/\/doi.org\/10.18203\/issn.2454-2156.IntJSciRep20221842.","journal-title":"Int J Sci Rep"},{"key":"4051_CR68","unstructured":"Arja A, Tadesse S, Agachew M et al. The Burden of Tuberculosis across Regions in Ethiopia: A Systematic Subnational Analysis for the Global Burden of Disease Study 2019. Ethiopian Journal of Health Development. 2023. eISSN: 1021\u20136790."},{"key":"4051_CR69","doi-asserted-by":"publisher","unstructured":"Demelash M, Nibret E, Hailegebriel T, Minichil Z, Mekonnen D. Prevalence of rifampicin resistant pulmonary tuberculosis using GeneXpert assay in Ethiopia, a systematic review and meta-analysis. Heliyon. 2023;9(9). https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19554.","DOI":"10.1016\/j.heliyon.2023.e19554"},{"key":"4051_CR70","doi-asserted-by":"publisher","first-page":"300","DOI":"10.3390\/tropicalmed7100300","volume":"7","author":"MA Reta","year":"2022","unstructured":"Reta MA, Tamene BA, Abate BB, Mensah E, Maningi NE, Fourie PB. Mycobacterium tuberculosis drug resistance in ethiopia: an updated systematic review and Meta-Analysis. Trop Med Infect Dis. 2022;7:300. https:\/\/doi.org\/10.3390\/tropicalmed7100300.","journal-title":"Trop Med Infect Dis"},{"issue":"4","key":"4051_CR71","doi-asserted-by":"publisher","first-page":"428","DOI":"10.22038\/IJBMS.2021.48628.11161","volume":"24","author":"F Khademi","year":"2021","unstructured":"Khademi F, Sahebkar A. An updated systematic review and meta-analysis on Mycobacterium tuberculosis antibiotic resistance in Iran (2013\u20132020). Iran J Basic Med Sci. 2021;24(4):428\u201336. https:\/\/doi.org\/10.22038\/IJBMS.2021.48628.11161.","journal-title":"Iran J Basic Med Sci"},{"issue":"1","key":"4051_CR72","doi-asserted-by":"publisher","first-page":"4","DOI":"10.5588\/pha.22.0047","volume":"13","author":"J Izudi","year":"2023","unstructured":"Izudi J, Bajunirwe F, Cattamanchi A. Increase in rifampicin resistance among people previously treated for TB. Public Health Action. 2023;13(1):4\u20136. https:\/\/doi.org\/10.5588\/pha.22.0047.","journal-title":"Public Health Action"},{"key":"4051_CR73","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40249-023-01107-x","volume":"12","author":"N Salari","year":"2023","unstructured":"Salari N, Kanjoori AH, Hosseinian-Far A, et al. Global prevalence of drug-resistant tuberculosis: a systematic review and meta-analysis. Infect Dis Poverty. 2023;12:57. https:\/\/doi.org\/10.1186\/s40249-023-01107-x.","journal-title":"Infect Dis Poverty"},{"key":"4051_CR74","doi-asserted-by":"publisher","first-page":"100379","DOI":"10.1016\/j.jctube.2023.100379","volume":"32","author":"M Rostamian","year":"2023","unstructured":"Rostamian M, Kooti S, Abiri R, Khazayel S, et al. Prevalence of Mycobacterium tuberculosis mutations associated with Isoniazid and rifampicin resistance: A systematic review and meta-analysis. J Clin Tuberculosis Other Mycobact Dis. 2023;32:100379. https:\/\/doi.org\/10.1016\/j.jctube.2023.100379.","journal-title":"J Clin Tuberculosis Other Mycobact Dis"},{"issue":"8","key":"4051_CR75","doi-asserted-by":"publisher","first-page":"932","DOI":"10.3390\/antibiotics10080932","volume":"10","author":"K Hajissa","year":"2021","unstructured":"Hajissa K, Marzan M, Idriss MI, Islam MA. Prevalence of Drug-Resistant tuberculosis in sudan: A systematic review and Meta-Analysis. Antibiotics. 2021;10(8):932. https:\/\/doi.org\/10.3390\/antibiotics10080932.","journal-title":"Antibiotics"},{"key":"4051_CR76","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1186\/s12889-015-1614-8","volume":"15","author":"D Lukoye","year":"2015","unstructured":"Lukoye D, Ssengooba W, Musisi K, et al. Variation and risk factors of drug resistant tuberculosis in sub-Saharan africa: a systematic review and meta-analysis. BMC Public Health. 2015;15:291. https:\/\/doi.org\/10.1186\/s12889-015-1614-8.","journal-title":"BMC Public Health"},{"issue":"7","key":"4051_CR77","doi-asserted-by":"publisher","first-page":"e0180996","DOI":"10.1371\/journal.pone.0180996","volume":"12","author":"CC Onyedum","year":"2017","unstructured":"Onyedum CC, Alobu I, Ukwaja KN. Prevalence of drug-resistant tuberculosis in nigeria: A systematic review and meta-analysis. PLoS ONE. 2017;12(7):e0180996. https:\/\/doi.org\/10.1371\/journal.pone.0180996.","journal-title":"PLoS ONE"},{"key":"4051_CR78","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/s12879-017-2323-y","volume":"17","author":"S Eshetie","year":"2017","unstructured":"Eshetie S, Gizachew M, Dagnew M, et al. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis. BMC Infect Dis. 2017;17:219. https:\/\/doi.org\/10.1186\/s12879-017-2323-y.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"4051_CR79","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1111\/tbed.14378","volume":"69","author":"A Alemu","year":"2022","unstructured":"Alemu A, Bitew ZW, Diriba G, Gumi B. Risk factors associated with drug-resistant tuberculosis in ethiopia: A systematic review and meta-analysis. Transbound Emerg Dis. 2022;69(5):2559\u201372. https:\/\/doi.org\/10.1111\/tbed.14378.","journal-title":"Transbound Emerg Dis"},{"key":"4051_CR80","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40794-018-0065-5","volume":"4","author":"T Girum","year":"2018","unstructured":"Girum T, Muktar E, Lentiro K, et al. Epidemiology of multidrug-resistant tuberculosis (MDR-TB) in ethiopia: a systematic review and meta-analysis of the prevalence, determinants and treatment outcome. Trop Dis Travel Med Vaccines. 2018;4:5. https:\/\/doi.org\/10.1186\/s40794-018-0065-5.","journal-title":"Trop Dis Travel Med Vaccines"},{"issue":"6","key":"4051_CR81","doi-asserted-by":"publisher","first-page":"e0197737","DOI":"10.1371\/journal.pone.0197737","volume":"13","author":"EA Mesfin","year":"2018","unstructured":"Mesfin EA, Beyene D, Tesfaye A, Admasu A, et al. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia. PLoS ONE. 2018;13(6):e0197737. https:\/\/doi.org\/10.1371\/journal.pone.0197737.","journal-title":"PLoS ONE"},{"issue":"11","key":"4051_CR82","doi-asserted-by":"publisher","first-page":"e0276701","DOI":"10.1371\/journal.pone.0276701","volume":"17","author":"G Diriba","year":"2022","unstructured":"Diriba G, Alemu A, Eshetu K, Yenew B, et al. Bacteriologically confirmed extrapulmonary tuberculosis and the associated risk factors among extrapulmonary tuberculosis suspected patients in ethiopia: A systematic review and meta-analysis. PLoS ONE. 2022;17(11):e0276701. https:\/\/doi.org\/10.1371\/journal.pone.0276701.","journal-title":"PLoS ONE"},{"key":"4051_CR83","doi-asserted-by":"publisher","unstructured":"Diriba G, Tola HH, Alemu A, Yenew B, Gamtesa DF, Kebede A. Drug resistance and its risk factors among extrapulmonary tuberculosis in ethiopia: A systematic review and meta-analysis. PLoS ONE. 2021;16(10). https:\/\/doi.org\/10.1371\/journal.pone.0258295.","DOI":"10.1371\/journal.pone.0258295"},{"key":"4051_CR84","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.2147\/IDR.S263795","volume":"13","author":"SK Sah","year":"2020","unstructured":"Sah SK, Bhattarai PR, Shrestha A, Dhami D, Shrestha R. Rifampicin-resistant Mycobacterium tuberculosis by GeneXpert MTB\/RIF and associated factors among presumptive pulmonary tuberculosis patients in Nepal. Infect Drug Resist. 2020;13:2911\u20139. https:\/\/doi.org\/10.2147\/IDR.S263795.","journal-title":"Infect Drug Resist"},{"issue":"3","key":"4051_CR85","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ijtb.2022.09.004","volume":"70","author":"ES Hassanin","year":"2023","unstructured":"Hassanin ES, Hussein M. Frequency of rifampicin-resistant Mycobacterium tuberculosis by GeneXpert MTB\/RIF assay and its correlates among 2605 probable tuberculosis patients in upper Egypt. Indian J Tuberculosis. 2023;70(3):345\u201355. https:\/\/doi.org\/10.1016\/j.ijtb.2022.09.004.","journal-title":"Indian J Tuberculosis"},{"issue":"6","key":"4051_CR86","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1111\/crj.12779","volume":"12","author":"V Boonsarngsuk","year":"2018","unstructured":"Boonsarngsuk V, Mangkang K, Santanirand P. Prevalence and risk factors of drug-resistant extrapulmonary tuberculosis. Clin Respir J. 2018;12(6):2101\u20139. https:\/\/doi.org\/10.1111\/crj.12779.","journal-title":"Clin Respir J"},{"key":"4051_CR87","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/s12887-023-04240-6","volume":"23","author":"Y Abebaw","year":"2023","unstructured":"Abebaw Y, Abebe M, Tola HH, et al. Pulmonary tuberculosis case notification and burden of drug resistance among children under 15 years of age in ethiopia: sub-analysis from third-round drug resistance tuberculosis survey. BMC Pediatr. 2023;23:418. https:\/\/doi.org\/10.1186\/s12887-023-04240-6.","journal-title":"BMC Pediatr"},{"key":"4051_CR88","doi-asserted-by":"publisher","unstructured":"Caws M, Marais B, Heemskerk D, Farrar J. Tuberculosis in adults and children. Springer Nature; 2015. https:\/\/doi.org\/10.1007\/978-3-319-19132-4.","DOI":"10.1007\/978-3-319-19132-4"},{"key":"4051_CR89","doi-asserted-by":"publisher","unstructured":"Sant\u2019Anna CC, March M, de FBP, Aur\u00edlio RB. Diagnosis of Tuberculosis among Children and Adolescents. Mycobacterium - Research and Development. InTech; 2018. Available from: https:\/\/doi.org\/10.5772\/intechopen.69227.","DOI":"10.5772\/intechopen.69227"},{"issue":"1","key":"4051_CR90","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-023-41937-9","volume":"14","author":"NA Menzies","year":"2023","unstructured":"Menzies NA, Allwood BW, Dean AS, Dodd PJ, et al. Global burden of disease due to rifampicin-resistant tuberculosis: A mathematical modeling analysis. Nat Commun. 2023;14(1):1\u20139. https:\/\/doi.org\/10.1038\/s41467-023-41937-9.","journal-title":"Nat Commun"},{"issue":"6","key":"4051_CR91","doi-asserted-by":"publisher","first-page":"e0000588","DOI":"10.1371\/journal.pgph.0000588","volume":"2","author":"ST Aung","year":"2022","unstructured":"Aung ST, Nyunt WW, Moe MM, Aung HL, Lwin T. The fourth National tuberculosis prevalence survey in Myanmar. PLOS Glob Public Health. 2022;2(6):e0000588. https:\/\/doi.org\/10.1371\/journal.pgph.0000588.","journal-title":"PLOS Glob Public Health"},{"key":"4051_CR92","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12879-024-10419-8","volume":"25","author":"AN Yirsaw","year":"2025","unstructured":"Yirsaw AN, Mengistie BA, Getachew E, Mekonnen GB, Shibabaw AA, et al. Prevalence of pulmonary tuberculosis and associated factors among adults living with HIV\/AIDS in Ethiopia, systematic review and meta-analysis. BMC Infect Dis. 2025;25:49. https:\/\/doi.org\/10.1186\/s12879-024-10419-8.","journal-title":"BMC Infect Dis"},{"issue":"9","key":"4051_CR93","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/tmi.12145","volume":"18","author":"M Bates","year":"2013","unstructured":"Bates M, Ahmed Y, Chilukutu L, Tembo J, Cheelo B, et al. Use of the Xpert\u00ae MTB\/RIF assay for diagnosing pulmonary tuberculosis comorbidity and multidrug-resistant TB in obstetrics and gynecology inpatient wards at the university teaching Hospital, Lusaka, Zambia. Tropical Med Int Health. 2013;18(9):1134\u201340. https:\/\/doi.org\/10.1111\/tmi.12145.","journal-title":"Tropical Med Int Health"},{"key":"4051_CR94","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s12879-018-3167-9","volume":"18","author":"B Demile","year":"2018","unstructured":"Demile B, Zenebu A, Shewaye H, et al. Risk factors associated with multidrug-resistant tuberculosis (MDR-TB) in a tertiary armed force referral and teaching hospital, Ethiopia. BMC Infect Dis. 2018;18:249. https:\/\/doi.org\/10.1186\/s12879-018-3167-9.","journal-title":"BMC Infect Dis"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-04051-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-025-04051-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-025-04051-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T03:02:30Z","timestamp":1768359750000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-025-04051-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4051"],"URL":"https:\/\/doi.org\/10.1186\/s12890-025-04051-8","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"2 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"\u201cConsent was not required by IRB or Ethics committee\u201d.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}